首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
【24h】

Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.

机译:格雷夫斯病和胸腺增生:胸腺体积与甲状腺功能的关系。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Thymic hyperplasia is associated with Graves' disease, particularly in young patients. The degree of thymic transformation is minimal in most but not all patients. In the latter group radiological measurements of thyroid size and their change with treatment have rarely been reported. We present two patients with Graves' disease and relatively rapid resolution of thymic enlargement after successful treatment of their hyperthyroidism. SUMMARY: Three patients with thyrotoxicosis secondary to Graves' disease and marked thymic enlargement were seen at our institution during a 2-year period. On computed tomography (CT) studies their volumes were 67, 81, and 54 cm(3). Thymic hyperplasia in the setting of Graves' disease was the diagnosis of exclusion. Two of the patients returned for follow-up after successful treatment of thyrotoxicosis as requested. On repeat CT their thymic volumes had decreased by 72% and 78%, respectively. Two types of histological modifications of the thymus have been described in association with Graves' disease, namely, thymic parenchyma hyperplasia and medullary lymphoid hyperplasia. The mechanisms underlying thymic transformation in patients with Graves' hyperthyroidism are not completely elucidated, but autoimmune processes underlying Graves' disease are presumed to play a role. The clinical course of our patients is consistent with earlier literature, indicating that thymic enlargement may occur in conjunction with Graves' hyperthyroidism, and that it usually resolves as hyperthyroidism is treated, but there is little quantitative pre- and posttreatment of hyperthyroidism data. CONCLUSION: Although every patient must be individually considered, it appears that thymic hyperplasia can be diagnosed in most Graves' hyperthyroid patients by considering the clinical context and appropriate radiologic studies such as CT. Raising awareness of the association of thymic hyperplasia in patients with Graves' hyperthyroidism and its resolution with the reversibility of the hyperthyroid state should prevent unnecessary thymic evaluation and surgery with its attendant risks.
机译:背景:胸腺增生与Graves病相关,尤其是在年轻患者中。在大多数但不是所有患者中,胸腺转化的程度很小。在后一组中,很少有放射学测量甲状腺大小及其随治疗变化的报道。我们介绍了两名Graves病患者,他们的甲状腺功能亢进症成功治疗后,胸腺增大相对较快地消退。摘要:在我们的机构中​​,有2名患者在3天内因Graves病继发甲状腺毒症并出现明显的胸腺肿大。在计算机断层扫描(CT)研究中,它们的体积分别为67、81和54 cm(3)。排除Graves病的胸腺增生是诊断。根据要求成功治疗甲状腺毒症后,其中两名患者返回随访。在重复CT上,他们的胸腺体积分别减少了72%和78%。已经描述了与格雷夫斯病有关的两种类型的胸腺组织学改变,即胸腺实质增生和髓样淋巴增生。尚未完全阐明Graves甲状腺功能亢进症患者胸腺转化的潜在机制,但推测Graves病潜在的自身免疫过程发挥了作用。我们患者的临床病程与较早的文献一致,表明胸腺增大可能与Graves甲状腺功能亢进症同时发生,并且通常在治疗甲状腺功能亢进症后即可解决,但对甲状腺功能亢进症数据的定量治疗前后均很少。结论:尽管每个患者都必须单独考虑,但似乎可以通过考虑临床情况和适当的影像学检查(例如CT)在大多数Graves甲状腺功能亢进患者中诊断出胸腺增生。提高对格雷夫斯甲状腺功能亢进症患者胸腺增生的关联的认识,以及其与甲状腺功能亢进状态的可逆性之间的关系,应避免进行不必要的胸腺评估和手术,并伴有其风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号